[HTML][HTML] Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors
M Merchant, J Moffat, G Schaefer, J Chan, X Wang… - PloS one, 2017 - journals.plos.org
… We discovered that pathway reactivation in RAS mutant models occurs at the level of CRAF
… clear pathway reactivation, we next examined effects of combining MEK and ERK inhibition. …
… clear pathway reactivation, we next examined effects of combining MEK and ERK inhibition. …
[HTML][HTML] MEK inhibitor resistance mechanisms and recent developments in combination trials
E Kun, YTM Tsang, CW Ng, DM Gershenson… - Cancer treatment …, 2021 - Elsevier
… evade MEK inhibition, and this often involves a re-wiring of the MAPK pathway to reactivate
… by which they can promote cell signaling, and reactivation of RTKs following MEK inhibition …
… by which they can promote cell signaling, and reactivation of RTKs following MEK inhibition …
[HTML][HTML] Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: we are not done yet
GA McArthur - Frontiers in oncology, 2015 - frontiersin.org
… that reactivate the RAF/MEK/ERK pathway (4–6) led to the hypothesis that addition of a …
outcomes of combined BRAF and MEK inhibition and frequent reactivation of RAF/MEK/ERK …
outcomes of combined BRAF and MEK inhibition and frequent reactivation of RAF/MEK/ERK …
[HTML][HTML] Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
GV Long, C Fung, AM Menzies, GM Pupo… - Nature …, 2014 - nature.com
… (MAPK) pathway with combined BRAF and MEK inhibition was … the BRAF inhibitor dabrafenib
combined with the MEK inhibitor … The phase III study of this combination versus dabrafenib (…
combined with the MEK inhibitor … The phase III study of this combination versus dabrafenib (…
[HTML][HTML] Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model
S Grossauer, K Koeck, NE Murphy, ID Meyers… - Oncotarget, 2016 - ncbi.nlm.nih.gov
… gavage daily suppressed MAPK pathway more effectively and … alone, combined BRAF V600E
and MEK inhibitor treatment … corresponding to sustained MAPK pathway inhibition. Results …
and MEK inhibitor treatment … corresponding to sustained MAPK pathway inhibition. Results …
[HTML][HTML] Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?
… These include reactivation of the MAPK pathway resulting in … of the FAK pathway, both
alone and in combination with MEK … of resistance to BRAF/MEK inhibition (www.clinicaltrials.gov; …
alone and in combination with MEK … of resistance to BRAF/MEK inhibition (www.clinicaltrials.gov; …
SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors
H Lu, C Liu, R Velazquez, H Wang, LM Dunkl… - Molecular cancer …, 2019 - AACR
… pathway reactivation in a large panel (n = 34) of KRAS-mutant cell lines, by measuring the
reduction of phospho-MEK … We also found that combining SHP2 and MEK inhibitors led to …
reduction of phospho-MEK … We also found that combining SHP2 and MEK inhibitors led to …
Molecular pathways: adaptive kinome reprogramming in response to targeted inhibition of the BRAF–MEK–ERK pathway in cancer
GL Johnson, TJ Stuhlmiller, SP Angus… - Clinical Cancer …, 2014 - AACR
… , allowing reactivation of ERK. Thus, MEK2 selectively escapes inhibition by allosteric … site
inhibitors suggests that MEK inhibitors will need to be used in combination with other inhibitors…
inhibitors suggests that MEK inhibitors will need to be used in combination with other inhibitors…
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
… MEK inhibitors in combination can override resistance to single agents 15 . We therefore
reasoned that combined RAF/MEK … to AZD6244 or CI-1040 in combination with PLX470 (1 μM …
reasoned that combined RAF/MEK … to AZD6244 or CI-1040 in combination with PLX470 (1 μM …
RAS–MAPK Reactivation Facilitates Acquired Resistance in FGFR1-Amplified Lung Cancer and Underlies a Rationale for Upfront FGFR–MEK Blockade
… in part through reactivation of MAPK pathway. Intriguingly, … redundantly reactivate RAS–MAPK
and combined upstream … FGFR inhibition combined with downstream blockade of MEK …
and combined upstream … FGFR inhibition combined with downstream blockade of MEK …
相关搜索
- concurrent mek mapk pathway reactivation
- mek inhibitors pathway reactivation
- pathway reactivation in ras mutant tumors
- raf mek erk pathway combination therapies
- mapk reactivation dabrafenib trametinib combination therapy
- mapk reactivation mek blockade
- glioma model mapk pathway reactivation
- pathway reactivation in kras mutant tumors
- combined mek ras mutant tumors
- erk inhibition pathway reactivation
- shp2 inhibition pathway reactivation
- combined braf mek inhibition
- combined raf mek inhibition